Umbilical cord mesenchymal stromal cells as critical COVID-19 adjuvant therapy: A randomized controlled trial.

Stem Cells Transl Med · 2021 · PMC8242692 · PMID 34102020

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

also showed a decreasing trend of IL‐6 after MSC application for moderate to severe COVID‐19 with no statistically significant value. 18 , 19 Consistently, Leng et al. reported an increase of IL‐10 in the MSCs group compared with the placebo group with a significant value ( P < .05).

also in 47,180 other papers

an increasing trendno p-value reported

There was a decreased trend in IL‐6 after MSC application; in contrast, an increasing trend was observed in the control group.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.